Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewBiotechnic (NBT) is a Spanish biotechnology company founded in 1999 and headquartered in Seville. The company specializes in molecular biology and genomics services, providing advanced diagnostic solutions for the agricultural, food, and industrial sectors. NBT's core offerings include GMO detection, pathogen identification in plants and animals, and food traceability through DNA analysis. As a contract research organization (CRO), the company supports plant breeding programs and industrial biotechnology projects through genomic analysis and molecular biology R&D. While primarily focused on ag-biotech and food safety, NBT leverages its molecular expertise for broader life science applications, including human health diagnostics and collaborative research in tissue engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewBiotechnic.